Glioblastoma

Researchers at Columbia University Medical Center ( CUMC ) have discovered that the fusion of two adjacent genes can...


Chromosomal translocations that generate in-frame oncogenic gene fusions are notable examples of the success of targeted cancer therapies. Gene fusions...


In a rigorous study of tumor tissue collected from 125 patients with aggressive brain cancers, researchers at Johns Hopkins say...


Investigational hunter immune cells engineered to seek out and attack a deadly brain cancer known as glioblastoma ( GBM )...


Renal cell carcinoma ( RCC ) accounts for approximately 330,000 cases diagnosed each year and 140,000 deaths worldwide. Most cases are...


City of Hope researchers at Duarte, California ( U.S. ) have reported on the successful treatment of a patient with...


Programmed cell death ligand-1 ( PD-L1 ) is widely expressed on antigen presenting cells ( APC ) and other immune...


Standard therapy for newly diagnosed glioblastoma is radiotherapy plus Temozolomide ( Temodal ). In this phase 3 study, researchers have...


Glioblastoma ( GBM ) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years,...


Bristol-Myers Squibb ( BMS ) has announced that a randomized blinded comparative phase 3 study evaluating Nivolumab versus Dacarbazine (...


Glioblastoma is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average...


Besides the use of Temozolomide ( Temodal ) and radiotherapy for patients with favourable methylation status, little progress has been...


A virus that remains dormant in the body might speed the progression of an aggressive form of brain cancer when...


The investigational drug AZD2171 ( Cediranib ) may help shrink tumors and prolong survival of patients with a relatively common,...


The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily...


Phase IV lung cancer study has confirmed the safety and outstanding efficacy benefit of Bevacizumab-based therapy in advanced non-small cell...


A Phase II clinical study of Bevacizumab ( Avastin ), administered alone or in combination with Irinotecan ( Camptosar...


Brain cancer patients with the poorest prognosis, those with a type of deadly tumor known as glioblastoma multiforme, may survive...


High-dose injections of Vitamin C, also known as Ascorbate or Ascorbic acid, reduced tumor weight and growth rate by about...


Researchers from the Massachusetts General Hospital ( MGH ) Cancer Center have found that AZD2171 ( Recentin ), a new...